April 10, 2013
Dr Klaus Beck heads up Amgen Development With three compounds in its Japan pipelines, Amgen Development K.K. is aiming to launch new products in the world’s second largest pharmaceutical market by 2016, revealed Klaus Beck, head of the Tokyo-based subsidiary...read more